Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CT
Graft Patency Following Off-Pump CABG Vs. On-Pump CABG Using 64 MDCT Bypass Graft CT Angiography
1 other identifier
interventional
350
1 country
1
Brief Summary
The purpose of this study is to compare graft patency rates following coronary artery bypass graft surgery performed by beating heart vs. conventional techniques using cardiac CT scanning to evaluate the bypass grafts.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2005
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2005
CompletedFirst Posted
Study publicly available on registry
November 29, 2005
CompletedStudy Start
First participant enrolled
December 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2007
CompletedSeptember 11, 2006
September 1, 2005
November 25, 2005
September 7, 2006
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Graft patency as determined by bypass graft CT angiography at 3 months and 12 months following surgery
Secondary Outcomes (5)
Length of Hospital Stay
Blood Loss
Operative Time
Post-op Complications
Quality of Life Assessment
Interventions
Eligibility Criteria
You may qualify if:
- Surgery indicated
- Patient is hemodynamically stable
- Isolated coronary artery surgery (no valve)
- No contraindications to cardiopulmonary bypass
- No previous surgery (not redo CABG)
You may not qualify if:
- critically ill patient with hemodynamic instability.
- concomitant cardiac procedures.
- inability to provide written informed consent.
- prior severe reaction to contrast dye :
- life-threatening anaphylactoid reactions
- cardiac dysrhythmias and arrest
- cardiovascular and pulmonary collapse
- elevated serum creatinine (\>150 mmol/L).
- contraindications to cardiopulmonary bypass.
- Age \< 18 years .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Trillium Health Centrelead
- Toshiba America Medical Systems, Inc.collaborator
Study Sites (1)
Trillium Health Centre
Mississauga, Ontario, L5B 1B8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tarang N Sheth, MD, FRCPC
Trillium Health Centre
- PRINCIPAL INVESTIGATOR
Gopal Bhatnagar, MD, FRCSC
Trillium Health Centre
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
November 25, 2005
First Posted
November 29, 2005
Study Start
December 1, 2005
Study Completion
October 1, 2007
Last Updated
September 11, 2006
Record last verified: 2005-09